Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DR26FJ76X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,592
Award facts
- Contract value 100% obligated
- $1,591.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of HUMIRA (adalimumab) pen 40 mg/0.4 mL injections, with a ceiling value of $1,591.92. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside award. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic immunosuppressant medication indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and other inflammatory conditions, making it a critical pharmaceutical component of federal military and veteran healthcare supply chains.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 global pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement through its comprehensive product portfolio spanning brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's IDC with DLA supports military healthcare programs worldwide and enables deliveries to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJ76X?
SPE2DR26FJ76X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FJ76X worth?
The government has obligated $1,592 on SPE2DR26FJ76X.
Is contract SPE2DR26FJ76X an order under another contract?
Yes. SPE2DR26FJ76X is a delivery order under SPE2DR25D6039, an indefinite delivery contract.
Was contract SPE2DR26FJ76X competed?
The extent of competition for SPE2DR26FJ76X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award